Ocugen Inc. buy BiotechBee
Start price
26.05.24
/
50%
€1.63
Target price
28.02.26
€3.50
Performance (%)
-49.35%
End price
14.12.24
€0.82
Summary
This prediction ended on 14.12.24 with a price of €0.82. The BUY prediction by BiotechBee for Ocugen Inc. performed very badly with a performance of -49.35%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocugen Inc. | -19.917% | -19.917% | 215.245% |
| iShares Core DAX® | -4.932% | -11.977% | -3.485% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 13.783% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.712% |
| iShares S&P 500 | -2.544% | -3.540% | 8.878% |
According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year